Status:
SUSPENDED
Individualized Assessment and Treatment for TMD
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute of Dental and Craniofacial Research (NIDCR)
Conditions:
Temporomandibular Joint Disorders
Orofacial Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Temporomandibular/orofacial pain disorders (TMD) are a group of painful conditions with multiple determinants.This proposal has two main goals: 1) to test a highly individualized, adaptive treatment f...
Detailed Description
Temporomandibular/orofacial pain disorders (TMD) are a group of painful conditions with multiple determinants. A number of psychosocial treatments for TMD have been developed, but overall effectivenes...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Jaw pain \> 3 mo; \> 3/10 on pain scale
- Positive Axis I diagnosis on the Diagnostic Criteria for temporomandibular disorders (DC/TMD), with or without disc displacement
- Positive on \> 1 of:
- Any myalgia diagnosis
- Any myofascial diagnosis
- Arthralgia
- TMD-related Headache
Exclusion
- Lack of fluency in English
- Previous invasive surgery for TMD, not including arthrography or arthrocentesis
- Extensive anatomical destruction or deterioration of the TM joint
- Diagnosed as having pain of neuropathic or odontogenic origin
- Carrying a diagnosis of psychosis
- Taking narcotic pain medication
- Any comorbid condition necessitating use of an intraoral appliance (e.g., obstructive sleep apnea)
- Pregnancy (excluded due to prescription of NSAIDs)
Key Trial Info
Start Date :
February 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04376333
Start Date
February 3 2021
End Date
June 1 2026
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UConn Health
Farmington, Connecticut, United States, 06030